---
categories: 
- Database
- Release
date: 2023-09-07
title: Database release
github_url: https://github.com/vanallenlab/moalmanac-db/releases/tag/v.2023-09-07
---
Added entries:
- (FDA) _BRCA1_ somatic and germline variants and sensitivity to abiraterone acetate in combination with niraparib for patients with metastatic castration-resistant prostate cancer.
- (FDA) _BRCA2_ somatic and germline variants and sensitivity to abiraterone acetate in combination with niraparib for patients with metastatic castration-resistant prostate cancer.
- (FDA) MSI-H and sensitivity to dostarlimab-gxly in combination with carboplatin and paclitaxel, followed by single agent dostarlimab-gxly, in endometrial cancer. 

Revised entries:
- (FDA) _EGFR_ p.T790M and sensitivity to osimertinib, resolved typo in description.
- (FDA) _RET_ fusions and sensitivity to pralsetinib, received regular approval from FDA after being previously granted accelerated approval. 
- All prior entries have been revised to have `last_updated` date be in ISO 8601 date standard of `YYYY-MM-DD`

Removed entries:
- (FDA) _RET_ somatic variants and sensitivity to pralsetinib in medullary thyroid cancer was [withdrawn voluntarily by Genentech](https://www.gene.com/media/statements/ps_062923). 

The field `publication_date` has been added to entries added or modified in this release. Our team will populate this field for prior records over future releases.